Neuronetics (STIM) FCF Margin Growth (1y) (2018 - 2026)
Neuronetics (STIM) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | -473.00 |
| 10 | Neuronetics | 224.51 Mn | 205.07 Mn | 21.22 Mn | 643.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 643.00 |
| Mar 31, 2026 | 2,536.00 |
| Dec 31, 2025 | 3,961.00 |
| Sep 30, 2025 | 2,486.00 |
| Jun 30, 2025 | 2,100.00 |
| Mar 31, 2025 | 1,691.00 |
| Dec 31, 2024 | -4,895.00 |
| Sep 30, 2024 | 2,468.00 |
| Jun 30, 2024 | 2,406.00 |
| Mar 31, 2024 | 2,921.00 |
| Dec 31, 2023 | 3,077.00 |
| Sep 30, 2023 | -940.00 |
| Jun 30, 2023 | 656.00 |
| Mar 31, 2023 | -592.00 |
| Dec 31, 2022 | 2,344.00 |
| Sep 30, 2022 | 1,275.00 |
| Jun 30, 2022 | -1,360.00 |
| Mar 31, 2022 | -1,735.00 |
| Dec 31, 2021 | -3,492.00 |
| Sep 30, 2021 | -2,373.00 |